Ensuring diverse representation in clinical research is not only a regulatory expectation but also a scientific imperative. A participant pool that reflects the demographic diversity of the broader population helps improve the generalizability of trial results and fosters health equity. Regulatory authorities, including the U.S. Food and Drug Administration (FDA), have issued formal guidance encouraging Sponsors and CROs to adopt Diversity Action Plans and report on demographic inclusion.

The DecenTrialz platform enables Sponsors and CROs to track, monitor, and improve participant diversity from the pre-screening stage, providing structured data capture and transparent insights into outreach efficacy.

Why Diversity Metrics Matter

• Scientific validity: Genetic, environmental, and cultural factors can influence treatment response.
• Regulatory compliance: The FDA’s 2020 guidance on enhancing diversity recommends inclusion tracking across race, ethnicity, age, sex, and geography.
• Trust and access: Representation builds community trust in research and promotes broader access to innovation.

How DecenTrialz Supports Diversity Tracking

While DecenTrialz focuses on the pre-screening stage, the platform is designed to capture and surface key demographic indicators that support sponsor-level diversity initiatives.

Structured Demographic Capture (Pre-Screen)

• Optional collection fields for:
  • Race and Ethnicity
  • Age Group
  • Sex Assigned at Birth / Gender Identity
  • Language Preferences
  • Zip Code / Geographic Zone
• All demographic fields are participant-voluntary and IRB-reviewed

Real-Time Metrics Dashboard

• Sponsors and CROs can:
  • View aggregated diversity trends across sites or trials
  • Filter results by demographic subgroups
  • Track outreach effectiveness across underrepresented populations

Outreach Equity Tools

• Insights from demographic breakdowns can inform:
  • Geo-targeted digital outreach campaigns
  • Culturally responsive recruitment messaging
  • Language translation needs for consent and education materials

Data Privacy and Ethical Considerations

All demographic data collected by DecenTrialz:

• Is anonymized and aggregated unless specific consent is given
• Is never shared with third parties or sponsors in a way that identifies the participant
• Adheres to HIPAA.
• Can be excluded from reports at participant request

Sponsors and CROs are encouraged to only use diversity data for planning and transparency purposes, not for participant inclusion or exclusion decisions.

Key Note: Diversity in clinical research is not an afterthought, it is a foundational element of ethical science. DecenTrialz provides Sponsors and CROs with the early-stage visibility needed to support inclusive study design and outreach, ensuring that the path to innovation reflects the populations it aims to serve.